NEUROONE MEDICAL TECHNOLOGIES Corp (NMTC) insider trading
Every open-market stock purchase and sale by NEUROONE MEDICAL TECHNOLOGIES Corp executives, directors, large shareholders and members of Congress, from SEC Form 4 filings. Sector: Other.
Insider activity at a glance
- David J. Wambeke (C-suite exec) bought $67K in the last 90 days, growing their stake 20%.
Last 12 months: insiders bought $737K (2 buys) and sold $54.9K (4 sales). Last close $0.98 on Oct 22, 2026.
Recent NMTC insider trades
| Date | Insider | Trade | Value |
|---|---|---|---|
| Aug 28, 2026 | Steve Mertens (CTO) | Bought (not open market) | — |
| Aug 28, 2026 | Emily J. Johns (C-suite exec) | Bought (not open market) | — |
| Aug 28, 2026 | Christopher Volker (CFO) | Bought (not open market) | — |
| Aug 28, 2026 | David A Rosa (CEO) | Bought (not open market) | — |
| Aug 28, 2026 | Mark Christianson (Director) | Bought (not open market) | — |
| Aug 28, 2026 | David J. Wambeke (C-suite exec) | Bought (not open market) | — |
| Aug 27, 2026 | David J. Wambeke (C-suite exec) | Bought | $67K |
| Jun 30, 2026 | Mark Christianson (Director) | Sold | $31.8K |
| Apr 3, 2026 | Edward Andrle (Director) | Bought (not open market) | — |
| Apr 3, 2026 | Edward Andrle (Director) | Bought (not open market) | — |
| Apr 3, 2026 | Paul Buckman (Director) | Bought (not open market) | — |
| Apr 3, 2026 | Paul Buckman (Director) | Bought (not open market) | — |
| Apr 3, 2026 | Jeffrey S Mathiesen (Director) | Bought (not open market) | — |
| Apr 3, 2026 | Jeffrey S Mathiesen (Director) | Bought (not open market) | — |
| Apr 3, 2026 | Jason Richard Mills (Director) | Bought (not open market) | — |
| Apr 3, 2026 | Jason Richard Mills (Director) | Bought (not open market) | — |
| Mar 31, 2026 | David A Rosa (CEO) | Sold (not open market) | $1.9K |
| Mar 31, 2026 | Steve Mertens (CTO) | Sold (not open market) | $704 |
| Mar 31, 2026 | Mark Christianson (Director) | Sold (not open market) | $197 |
| Mar 30, 2026 | Mark Christianson (Director) | Sold | $11.4K |
| Mar 13, 2026 | Mark Christianson (Director) | Sold | $80 |
| Mar 12, 2026 | Mark Christianson (Director) | Sold | $654 |
| Mar 11, 2026 | Mark Christianson (Director) | Sold | $1.7K |
| Mar 10, 2026 | Mark Christianson (Director) | Sold | $9.3K |
| Mar 1, 2026 | David J. Wambeke (C-suite exec) | Bought | $670K |
Who's trading NMTC
- Steve Mertens, CTO: other filings, last Aug 28, 2026
- Emily J. Johns, C-suite exec: other filings, last Aug 28, 2026
- David A Rosa, CEO: other filings, last Aug 28, 2026
- Christopher Volker, COO: other filings, last Aug 28, 2026
- Mark Christianson, Director: sold $54.9K (6 sales), last Aug 28, 2026
- David J. Wambeke, C-suite exec: bought $737K (2 buys), last Aug 28, 2026
- Edward Andrle, Director: other filings, last Apr 3, 2026
- Paul Buckman, Director: other filings, last Apr 3, 2026
- Jeffrey S Mathiesen, Director: other filings, last Apr 3, 2026
- Jason Richard Mills, Director: other filings, last Apr 3, 2026
Get free alerts when an insider at NEUROONE MEDICAL TECHNOLOGIES Corp files a new trade →